Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott B Patten

Showing results (81-90 of 534) with videos related to

Pageof 54
Sort By:
Neurology|September 11, 2002
Interferon beta1a and depression in secondary progressive MS: data from the SPECTRIMS TrialScott B Patten, Luanne M Metz,
Depression and Anxiety|October 20, 2007
Non-remission of depression in the general population as assessed by the HAMD-7 scaleAndrew G Bulloch, Scott B Patten
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|September 22, 2006
Sedative hypnotic use in AlbertaAliya Kassam, Brian Carter, Scott B Patten
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|January 8, 2015
Key ingredients of anti-stigma programs for health care providers: a data synthesis of evaluative studiesStephanie Knaak, Geeta Modgill, Scott B Patten
BMJ (Clinical Research Ed.)|March 6, 2015
Adjunctive treatment with quetiapine for major depressive disorder: are the benefits of treatment worth the risks?Tamara Pringsheim, David Gardner, Scott B Patten
Journal of Child and Adolescent Psychopharmacology|December 6, 2011
The pharmacoepidemiology of antipsychotic medications for Canadian children and adolescents: 2005-2009Tamara Pringsheim, Darren Lam, Scott B Patten
Community Health Equity Research & Policy|November 6, 2025
From Power Over to Power With: The PARTNER Tool for Transformation in Participatory Health ResearchSandy Rao, Gina Dimitropoulos, Scott B Patten
Neurology. Clinical Practice|November 30, 2017
Depression in epilepsy, migraine, and multiple sclerosis: Epidemiology and how to screen for itNathalie Jetté, Farnaz Amoozegar, Scott B Patten
Psychosomatics|December 12, 2007
Chronic obstructive lung diseases and prevalence of mood, anxiety, and substance-use disorders in a large population sampleScott B Patten, Jeanne V A Williams
Social Psychiatry and Psychiatric Epidemiology|April 24, 2007
Assessment of physical etiologies for mood and anxiety disorders in structured diagnostic interviewsScott B Patten, Jeanne V A Williams
Pageof 54

Showing results (81-90 of 534) with videos related to

Sort By:
Pageof 54
Neurology|September 11, 2002
Interferon beta1a and depression in secondary progressive MS: data from the SPECTRIMS TrialScott B Patten, Luanne M Metz,
Depression and Anxiety|October 20, 2007
Non-remission of depression in the general population as assessed by the HAMD-7 scaleAndrew G Bulloch, Scott B Patten
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|September 22, 2006
Sedative hypnotic use in AlbertaAliya Kassam, Brian Carter, Scott B Patten
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|January 8, 2015
Key ingredients of anti-stigma programs for health care providers: a data synthesis of evaluative studiesStephanie Knaak, Geeta Modgill, Scott B Patten
BMJ (Clinical Research Ed.)|March 6, 2015
Adjunctive treatment with quetiapine for major depressive disorder: are the benefits of treatment worth the risks?Tamara Pringsheim, David Gardner, Scott B Patten
Journal of Child and Adolescent Psychopharmacology|December 6, 2011
The pharmacoepidemiology of antipsychotic medications for Canadian children and adolescents: 2005-2009Tamara Pringsheim, Darren Lam, Scott B Patten
Community Health Equity Research & Policy|November 6, 2025
From Power Over to Power With: The PARTNER Tool for Transformation in Participatory Health ResearchSandy Rao, Gina Dimitropoulos, Scott B Patten
Neurology. Clinical Practice|November 30, 2017
Depression in epilepsy, migraine, and multiple sclerosis: Epidemiology and how to screen for itNathalie Jetté, Farnaz Amoozegar, Scott B Patten
Psychosomatics|December 12, 2007
Chronic obstructive lung diseases and prevalence of mood, anxiety, and substance-use disorders in a large population sampleScott B Patten, Jeanne V A Williams
Social Psychiatry and Psychiatric Epidemiology|April 24, 2007
Assessment of physical etiologies for mood and anxiety disorders in structured diagnostic interviewsScott B Patten, Jeanne V A Williams
Pageof 54